SK’s New Sleep Disorder Drug Wins FDA Approval

SEOUL, Mar. 21 (Korea Bizwire) — A biopharmaceutical affiliate of South Korea’s SK Group said Thursday that it has won sales approval from the U.S. Food and Drug Administration (FDA) for its sleep disorder drug. The product, named Solriamfetol, is the country’s first indigenous drug for the central nervous system to receive the greenlight from [...]